through multidisciplinary expertise and patented solutions for a healthier tomorrow.
Innoway is a start-up company with multiple patents, prototypes and is aiming to become an international biotechnology company.
At Innoway R&D, we design innovative medical devices, produce treatment approaches, produce prototypes and carry out the necessary validation studies by a multidisciplinary team of medical doctors, engineers and basic sciences.
Innoway R&D is dedicated to revolutionizing healthcare through the innovative design and development of medical devices, leveraging a multidisciplinary team to create validated solutions that enhance patient outcomes and drive advancements in medical technology.
Our vision is to become a leading international biotechnology company, recognized for our pioneering spirit and commitment to transforming scientific insights into groundbreaking healthcare solutions that improve the quality of life worldwide.
Initus-V 222 system combines ergonomic wearable Far-UVC resistant textiles and a filtered 222 nm Far-UVC light source to allow Far-UVC technology to be used without any restriction in the presence of humans all over the world under all regulatory standards.
Initus-V 222 system can disinfect both surface and air simultaneously thus reducing disinfection costs and increasing safety against infectious diseases.
Initus-V 222 system is eliminating the long-term damage hesitation due to lack of long term clinical human studies and enabling continuous air and surface disinfection without any safety or regulatory concern.
CE markSoftware application“NeuroSpot” is a patent-granted software application. Once the optimum burr hole point is determined by the software, red signal turns to green and exact entry point on the skull is pointed.
Patent-grantedMobile appAbakus is a medical application based on a mobile phone or tablet and calculates drug dosages, pediatric growth charts, cardiopulmonary and emergency interventions based on a single picture of the patient.
Working prototypeMech. retractorThe retractor we have developed in Innoway R&D is very simple low cost, disposable, easily sterilized, pneumatically actuated pair of tongs. As the connection hose is flexible no force or action is transferred to the operation zone.
Advanced heart failure and cardiogenic shock are diseases with high mortality and require effective early intervention. A permanent and temporary support system that works with principles separate from existing axial pumps, centrifugal pumps, IABP and ECMO that can be placed percutaneously.
A retractor in order to access effectively to the surgical area and form a platform composed of stabilizer legs to optimize the operation area with correct angle and shape to create ergonomically accurate position and comprising pressure sensors measuring the transmission force applied on the surrounding tissue in real time.
The invention relates to a coronary plaque liquefaction/removal catheter capable of reaching all coronary arteries in a three-dimensional and 360-degree manner for use in atherosclerotic vascular diseases.
Recent news from Innoway and technological advancement in medicine and health care.
Initus-V 222 system has received CE mark in 2023.
Study title was “Investigation of heavy metals in coronary artery tissue in autopsy cases: Time for paradigm change?” and received best research award.
“Phosphatidylcholine/deoxycholate dissolves atherosclerotic plaques: A new interventional therapy?” study was presented in AICT ASIA PCR 2021 congress.
Initus-V 222 system clinical trial results were presented in 2021 IUVA World Congress with a title “Results of Far-UVC and Protective Textile Based System For Germ Free Angiography Units”.
Curatio Dualis system was presented in EuroPCR 2019 Innovator day.
